Physician profile
Puja Sethi
NPI 1760753271
$5,443.98
in general payments reported to CMS, 2019-2025
22 companies · $1,703 in 2025
The $1,703 reported for 2025 was more than what 80% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $232 · 2021: $691 · 2022: $422 · 2023: $827 · 2024: $1,059 · 2025: $1,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,409 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,408.85 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,949.40 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $525.71 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $504.37 | 2024-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $458.45 | 2023-2025 | Lumryz |
| Novo Nordisk INC | $289.84 | 2021-2025 | Wegovy |
| Itamar Medical INC | $249.20 | 2023-2025 | Watchpatone |
| Genentech USA, INC. | $235.23 | 2021-2022 | |
| Boston Scientific Corporation | $186.90 | 2025 | Apollo Esg System |
| Genzyme Corporation | $149.75 | 2023 | |
| Intercept Pharmaceuticals, INC. | $120.65 | 2021 | |
| Amarin Pharma, INC. | $107.26 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $104.01 | 2021 | |
| Arbor Pharmaceuticals, INC. | $100.03 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.16 | 2024 | Lifevest |
| Lilly USA, LLC | $98.38 | 2024-2025 | Zepbound, Jardiance |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76.40 | 2024 | |
| Eisai INC. | $70.27 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.34 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $25.74 | 2021 | |
| Resmed Corp | $25.27 | 2025 | |
| Hologic Sales and Service, LLC | $21.08 | 2024 | Aptima |
| Exact Sciences Corporation | $17.54 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.